Skip to main content
Caplight Logo









Scriptr Global, Inc.

Scriptr Global, Inc.

Private
Houston, TexasHealthcare & Life Scienceshttps://scriptr.com/

Last Round

Series A

Extension

Mar 8, 2017

Total Funding Raised

$9M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Scriptr Global, Inc. is a biotechnology company that develops gene and RNA-based therapeutics for rare diseases using its proprietary StitchR and CirculR platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyRNA therapeuticsbiotech platformrare disease treatmentStitchRCirculRgenetic engineeringmRNA stabilitydrug discoverybiotech licensingAAV vectorsgene replacementprecision medicinebiotech startupnext-gen therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scriptr Global, Inc. Comparables

Compare Scriptr Global, Inc. with similar companies based on industry and business-model similarity.

Scriptr Global, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bristol Myers Squibb
83%
Tacit Therapeutics
83%
Ascidian Therapeutics
82%

Scriptr Global, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 8, 2017
Series AFeb 10, 2016

Scriptr Global, Inc. Investors

Notable investors and investment history

Scriptr Global, Inc. investors
InvestorRounds
IM CapitalSeries A Extension
Middle East Venture PartnersSeries A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 46% MoM.

Scriptr Global, Inc. Filings

Explore SEC and related filing metadata, where available.

Scriptr Global, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Scriptr Global, Inc.'s valuation, stock price, and market status.

Is Scriptr Global, Inc. a public or private company?

Scriptr Global, Inc. is a private company.

What is the current stock price of Scriptr Global, Inc.?

Scriptr Global, Inc. is a private company with no public stock price. Caplight tracks Scriptr Global, Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Scriptr Global, Inc. worth (valuation)?

Valuation information for Scriptr Global, Inc. is not publicly available.

Can I buy Scriptr Global, Inc. stock?

Scriptr Global, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Scriptr Global, Inc.'s last funding round?

Scriptr Global, Inc.'s most recent funding round was Series A Extension on March 8, 2017.

Who are the main investors in Scriptr Global, Inc.?

Key investors in Scriptr Global, Inc. include Middle East Venture Partners.

Will Scriptr Global, Inc. IPO soon?

No public IPO plans have been announced for Scriptr Global, Inc..

How can I track Scriptr Global, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Scriptr Global, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHouston, Texas
Employee Range1
Year Founded2019
Last FundingMar 8, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?